10-Q: ZeroStack Corp. Q2 2026: Digital Assets Drive Revenue Amidst Net Loss
Quarterly Report
ZeroStack Corp. reports increased revenue driven by digital asset staking, but a significant net loss due to digital asset value depreciation and operational costs.
Summary
- ZeroStack Corp. reported total revenue of $13.7 million for the three months ended June 30, 2026, up from $9.7 million in the prior year period, primarily due to pharmaceutical sales and the commencement of 0G token staking.
- The company incurred a net loss of $24.6 million for the three months ended June 30, 2026, compared to a net loss of $2.4 million in the same period last year, largely driven by a $21.8 million loss from changes in the fair value of digital assets.
- For the six months ended June 30, 2026, revenue was $20.9 million, an increase from $16.6 million in the prior year, while the net loss widened to $61.3 million from $3.2 million, significantly impacted by an $82.5 million loss from digital asset fair value changes.
- The company's balance sheet shows total assets of $25.2 million as of June 30, 2026, a substantial decrease from $130.2 million at the end of 2025, primarily due to the decline in digital asset values.
- Total liabilities decreased significantly to $11.4 million from $59.7 million, largely due to the repayment of long-term debt.
- Shareholders' equity also decreased to $13.8 million from $70.6 million, reflecting the accumulated deficit.
- The company completed the acquisition of Texas Blocker Corp. on July 20, 2026, which added approximately 148 million 0G tokens to its treasury.
- Substantial doubt exists regarding the company's ability to continue as a going concern due to its accumulated deficit and reliance on digital asset monetization.
Sentiment
Score: 3
Explanation: StockSavvy.ai views this filing as negative due to the significant net loss, substantial decrease in asset value, and the ongoing going concern warning, despite revenue growth from new digital asset initiatives.
Positives
- Revenue increased by 40.7% to $13.7 million for the three months ended June 30, 2026, compared to $9.7 million in the prior year period.
- Pharmaceutical revenue from the Phatebo subsidiary remained strong, contributing $12.6 million in the current quarter.
- Digital asset staking revenue commenced in 2026, generating $1.0 million in the three months ended June 30, 2026.
- Gross profit margin improved to 12% for the three months ended June 30, 2026, from 6% in the prior year period, driven by staking revenue.
- The acquisition of Texas Blocker Corp. on July 20, 2026, significantly increased the company's 0G token holdings to approximately 223 million.
- Liabilities decreased substantially from $59.7 million to $11.4 million, primarily due to debt repayment.
Negatives
- The company reported a net loss of $24.6 million for the three months ended June 30, 2026, a significant increase from a $2.4 million net loss in the prior year period.
- A substantial loss of $21.8 million from changes in the fair value of digital assets negatively impacted the current quarter's results.
- The company's total assets decreased by over 80% from $130.2 million at December 31, 2025, to $25.2 million at June 30, 2026, largely due to the decline in digital asset values.
- Shareholders' equity decreased from $70.6 million to $13.8 million.
- The company has an accumulated deficit of $339.1 million as of June 30, 2026.
- Substantial doubt exists about the company's ability to continue as a going concern.
Risks
- Fluctuations in the market price of 0G Tokens or any other digital assets held by the company.
- The possibility that 0G Tokens or other digital assets could be classified as a 'security'.
- Decrease in liquidity of 0G Tokens or other digital assets.
- The company's ability to continue as a going concern absent access to liquidity sources.
- Risks associated with cybersecurity and the protection of confidential information.
- The reliance on staking revenue and the volatility of staking yields.
- Potential delisting from exchanges, leading to reduced liquidity of Common Shares.
- The company's limited operating history and history of net losses.
Future Outlook
Management expects existing cash balances, combined with the monetization of digital assets earned through staking activities, to provide sufficient liquidity to fund forecasted operating expenditures for the next twelve months. The company may also monetize a portion of its digital asset holdings if necessary. However, substantial doubt exists about the company's ability to continue as a going concern.
Management Comments
- Management believes its current cash balances and expected staking rewards will provide sufficient liquidity for the next twelve months.
- The company's strategy is to use staking rewards to fund operating activities and working capital requirements.
- Management has implemented plans to mitigate going concern risks but cannot conclude they are probable of effectively mitigating the conditions.
- The company is now classified as a U.S. domestic corporation for U.S. federal income tax purposes following the Texas Blocker Corp. acquisition.
Industry Context
StockSavvy.ai notes that ZeroStack Corp.'s strategic shift towards a decentralized AI treasury, leveraging 0G tokens and staking, aligns with broader trends in the digital asset and AI infrastructure sectors. However, the significant impact of digital asset price volatility on financial results highlights the inherent risks in this emerging market.
Comparison to Industry Standards
- The company's significant net loss and accumulated deficit are concerning when compared to established pharmaceutical distributors. However, its digital asset strategy is in a nascent stage, making direct comparisons difficult.
- The substantial decline in digital asset holdings' fair value is a common challenge for companies in this sector, as seen with other crypto-focused entities experiencing market downturns.
- The company's reliance on staking rewards for liquidity is a developing model within the digital asset space, with yields subject to significant network and market fluctuations, unlike traditional revenue streams.
Corporate Governance
| Change Type | Description | Effective Date | Impact Assessment |
|---|---|---|---|
| Board Composition | Following the passing of Harold Wolkin, Laurence Zeifman was appointed as a director on January 6, 2026, restoring the board's majority of independent directors. | 2026-01-06 | Regained compliance with Nasdaq Listing Rule 5605(b)(1) regarding board composition. |
| Audit Committee Composition | Laurence Zeifman was appointed to the Audit Committee on January 6, 2026, increasing its membership to three independent directors. | 2026-01-06 | Regained compliance with Nasdaq Listing Rule 5605(c)(2)(A) regarding audit committee composition. |
| Compensation Committee Composition | Laurence Zeifman was appointed to the Compensation Committee on January 6, 2026, increasing its membership to three independent directors. | 2026-01-06 | Maintained compliance with Nasdaq Listing Rule 5605(d)(2) regarding compensation committee composition. |
| Nominating and Corporate Governance Committee Composition | Laurence Zeifman was appointed to the Nominating and Corporate Governance Committee on January 6, 2026, increasing its membership to three independent directors. | 2026-01-06 | Maintained compliance with Nasdaq Listing Rule 5605(e)(1) regarding nominating and corporate governance committee composition. |
Legal Proceedings
- A lessor is claiming breach of lease and written guaranty agreements against the Company and Vessel Brand Inc. for $1.3 million in unpaid rent, interest, and attorneys' fees.
- The Company has recognized a provision of $1.3 million for this legal dispute.
Related Party Transactions
- On March 31, 2026, Texas Blocker Corp., formed by CEO Daniel Reis-Faria and CFO Dany Vaiman, entered into securities contribution agreements with investors.
- Michael Heinrich, Executive Chairman, was the CEO of Zero Gravity Labs Inc. at the time of issuance and settlement of the Zero Gravity Convertible Note.
- The sale of the Cannabis Business on September 26, 2025, involved investors who were directors at the time, including Clifford Starke and Sammy Dorf, and CFO Dany Vaiman.
Stakeholder Impact
- Shareholders face continued dilution risk from potential future capital raises and the significant net losses impacting equity value.
- Creditors and lenders may be concerned about the company's going concern status and its ability to service debt.
- Employees may be concerned about the company's financial stability and future prospects.
- Suppliers may face payment risks given the company's liquidity challenges.
Next Steps
- Continue to monitor and manage digital asset holdings and staking activities.
- Focus on integrating Texas Blocker Corp. and leveraging its 0G token holdings.
- Continue to fund operations through cash balances and monetization of digital assets.
- Address going concern issues through operational improvements and potential further capital raises.
Key Dates
| Date | Description |
|---|---|
| 2025-09-26 | Sale of legacy hemp and cannabis business completed. |
| 2025-10-23 | Zero Gravity Convertible Note issued. |
| 2026-01-21 | Company began staking its 0G Tokens. |
| 2026-03-31 | Texas Blocker Corp. securities contribution agreements and share exchange agreement entered into; Zero Gravity Convertible Note settled. |
| 2026-04-21 | Phatebo short-term borrowing repaid. |
| 2026-07-20 | Exchange with Texas Blocker Corp. completed, making it a wholly-owned subsidiary. |
| 2026-07-27 | Date of the report filing. |
| 2026-07-31 | Report signed by CEO and CFO. |
Recommendation
holdThe company shows revenue growth driven by its new digital asset strategy and has completed a significant acquisition that bolsters its 0G token holdings. However, the substantial net losses, significant decline in asset values, and the persistent going concern warning necessitate a cautious 'hold' stance until there is clearer evidence of financial stabilization and a path to profitability.
Keywords
ZeroStack Corp, 0G Token, Digital Assets, AI Infrastructure, Blockchain, Staking Rewards, Pharmaceutical Distribution, Form 10-Q
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.